Literature DB >> 17565936

Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial.

Mesut Oktem1, Derya Eroglu, Hilal B Karahan, Nilgun Taskintuna, Esra Kuscu, Hulusi B Zeyneloglu.   

Abstract

The objective of this study was to evaluate the efficacy of fluoxetine and black cohosh in the treatment of women with postmenopausal symptoms. A total of 120 healthy women with menopausal symptoms were recruited to this prospective study with a follow-up period of 6 mo. They were randomly assigned to 1 of 2 groups and were treated with fluoxetine or black cohosh. After entry into the study, patients were examined at the first, second, third, and sixth months of the treatment period. The women kept diaries in which they reported the daily number and intensity of hot flushes and night sweats. In addition, at the beginning and end of the third month, they completed questionnaires consisting of a modified Kupperman Index, Beck's Depression Scale, and a RAND-36 Quality-of-Life Questionnaire. Statistically significant differences were noted in the Kupperman Index and Beck's Depression Scale at the end of the third month in both groups compared with baseline values. In the black cohosh group, the Kupperman Index decreased significantly compared with that in the fluoxetine group by the end of the third month. On the other hand, in the fluoxetine group, Beck's Depression Scale decreased significantly compared with that in the black cohosh group. Monthly scores for hot flushes and night sweats decreased significantly in both groups; however, black cohosh reduced monthly scores for hot flushes and night sweats to a greater extent than did fluoxetine. At the end of the sixth month of treatment, black cohosh reduced the hot flush score by 85%, compared with a 62% result for fluoxetine. By the sixth month of the study, 40 women had discontinued the study--20 (33%) in the fluoxetine group and 20 (33%) in the black cohosh group. Compared with fluoxetine, black cohosh is more effective for treating hot flushes and night sweats. On the other hand, fluoxetine is more effective in improvements shown on Beck's Depression Scale.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565936     DOI: 10.1007/BF02849914

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  18 in total

Review 1.  Black cohosh for the management of menopausal symptoms : a systematic review of clinical trials.

Authors:  Carlos Palacio; Ghania Masri; Arshag D Mooradian
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

2.  Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches.

Authors:  Joshua Z Tal; Sooyeon A Suh; Claire L Dowdle; Sara Nowakowski
Journal:  Curr Psychiatry Rev       Date:  2015

Review 3.  Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.

Authors:  K Simon Yeung; Marisol Hernandez; Jun J Mao; Ingrid Haviland; Jyothirmai Gubili
Journal:  Phytother Res       Date:  2018-02-21       Impact factor: 5.878

4.  Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial.

Authors:  Mahnaz Shahnazi; Jila Nahaee; Sakineh Mohammad-Alizadeh-Charandabi; Somaye Bayatipayan
Journal:  J Caring Sci       Date:  2013-06-01

Review 5.  Non-hormonal treatment strategies for vasomotor symptoms: a critical review.

Authors:  Elise Hall; Benicio N Frey; Claudio N Soares
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

Review 6.  Ethnobotany, Phytochemistry, Traditional and Modern Uses of Actaea racemosa L. (Black cohosh): A Review.

Authors:  Sofia Salari; Mohammad Sadegh Amiri; Mahin Ramezani; Ali Tafazoli Moghadam; Sepideh Elyasi; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Actual status of veralipride use.

Authors:  Sebastián Carranza-Lira
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

8.  Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause.

Authors:  Jay D Amsterdam; Yubing Yao; Jun James Mao; Irene Soeller; Kenneth Rockwell; Justine Shults
Journal:  J Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.153

9.  Dose-Dependent Effects of the Cimicifuga racemosa Extract Ze 450 in the Treatment of Climacteric Complaints: A Randomized, Placebo-Controlled Study.

Authors:  Ruediger Schellenberg; Reinhard Saller; Lorenzo Hess; Jörg Melzer; Christian Zimmermann; Juergen Drewe; Catherine Zahner
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-23       Impact factor: 2.629

Review 10.  Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric Complaints.

Authors:  A-M Beer; A Neff
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.